Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/TLRY stock hub

TSX/TLRY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/TLRYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

907.9M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/TLRY

In the news

Latest news · TSX/TLRY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-63.2

P25 -121.5P50 -40.9P75 0.5

ROIC-4

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/TLRY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CA
Employees	2,842
Employees Change	192%
Employees Change Percent	7.25
Enterprise value	CAD 997.4M
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	US88688T1007
Last refreshed	2026-05-10
Market cap	CAD 907.9M
Price	CAD 7.63
Price currency	CAD
Rev Per Employee	411,824.02x
Sector	Healthcare
Sic	2834
Symbol	tsx/TLRY
Website	https://www.tilray.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-201.97%
EV Earnings	-0.54x
EV/EBITDA	34.64x
EV/FCF	-9.91x
EV/Sales	0.85x
FCF yield	-11.08%
Forward P/E	10.96x
P/B ratio	0.44x
P/S ratio	0.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.52%
EBITDA Margin	2.07%
Gross margin	27.68%
Gross Profit	CAD 323.9M
Gross Profit Growth	-7.59%
Gross Profit Growth Q	5.54%
Gross Profit Growth3 Y	44.64%
Gross Profit Growth5 Y	23.44%
Net Income	CAD -1.8B
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-169.76%
Profit Margin	-156.67%
Profit Per Employee	CAD -645,186
ROA	-1.47
Roa5y	-1.87
ROCE	-3.55
ROE	-63.16
Roe5y	-30.72
ROIC	-4.04
Roic5y	-3.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	29.35%
Cagr3y	-40.91%
Cagr5y	-47.79%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	3.83x
Revenue Growth Q	11.28x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	12.91x
Revenue Growth5 Y	12.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.31
Assets	CAD 2.8B
Cash	CAD 299.9M
Current Assets	CAD 982.6M
Current Liabilities	CAD 352.1M
Debt	CAD 432.4M
Debt EBITDA	CAD 15.07
Debt Equity	CAD 0.21
Debt FCF	CAD -4.3
Equity	CAD 2.1B
Interest Coverage	-1.99
Liabilities	CAD 748.8M
Long Term Assets	CAD 1.8B
Long Term Liabilities	CAD 396.7M
Net Cash	CAD -132.5M
Net Cash By Market Cap	CAD -14.59
Net Debt EBITDA	CAD 5.47
Net Debt Equity	CAD 0.06
Tangible Book Value	CAD 1.1B
Tangible Book Value Per Share	CAD 9.17
WACC	13.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.79
Inventory Turnover	2.23
Net Working Capital	CAD 374.8M
Quick ratio	1.31
Working Capital	CAD 628.9M
Working Capital Turnover	CAD 2.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	29.32%
200-day SMA	13.44
3Y total return	-79.38%
50-day SMA	9.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.12%
All Time High	278.8
All Time High Change	-97.26%
All Time High Date	2021-06-09
All Time Low	4.85
All Time Low Change	57.32%
All Time Low Date	2025-06-20
ATR	0.59
Beta	2.11
Ch YTD	-38.52
High	7.75
High52	32.3
High52 Date	2025-10-09
High52ch	-76.38%
Low	7.51
Low52	4.85
Low52 Date	2025-06-23
Low52ch	57.32%
Ma50ch	-17.13%
Price vs 200-day SMA	-43.25%
RSI	34.62
RSI Monthly	36.29
RSI Weekly	36.41
Sharpe ratio	0.74x
Sortino ratio	1.61
Total Return	-26.41%
Tr YTD	-38.52
Tr1m	-15.13%
Tr1w	-8.95%
Tr3m	-26.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -88.1M
Operating margin	-7.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	118,367,051%
Net Borrowing	-21,693,716.5
Shares Insiders	0.77%
Shares Institutions	7.54%
Shares Qo Q	2.11%
Shares Yo Y	26.41%
Short Float	0.98%
Short Ratio	3.28
Short Shares	0.98

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -151.3M
Average Volume	857,371.45x
Bv Per Share	18.27
CAPEX	CAD -39.8M
Ch1m	-15.13
Ch1w	-8.95
Ch1y	29.32
Ch3m	-26.42
Ch3y	-79.38
Ch5y	-96.12
Ch6m	-56.15
Change	-1.17%
Change From Open	-1.04
Close	7.72
Days Gap	-0.13
Depreciation Amortization	112,562,897
Dollar Volume	4,500,883.6
Earnings Date	2026-07-24
EBIT	CAD -88.1M
EBITDA	CAD 24.2M
EPS	CAD -17.22
F Score	4
FCF	CAD -100.6M
FCF EV Yield	-10.09x
Financing CF	108,359,946
Fiscal Year End	May
Goodwill	1,028,500,067.5
Income Tax	CAD -166.2M
Investing CF	12,136,663
Is Primary Listing	0
Last Earnings Date	2026-04-01
Last Report Date	2026-02-28
Last Split Date	2025-12-02
Last Split Type	Reverse
Ma150	12.87
Ma150ch	-40.71%
Ma20	8.93
Ma20ch	-14.56%
Net CF	67,568,485
Next Earnings Date	2026-07-24
Open	7.71
Position In Range	50
Ppne	766,842,596.4
Price Date	2026-05-08
Price EBITDA	CAD 37.49
Ptbv Ratio	0.85
Relative Volume	0.69x
Revenue	1,170,403,869x
SBC By Revenue	4.33x
Share Based Comp	50,673,977
Tax By Revenue	-14.2x
Tr6m	-56.15%
Volume	589,893
Z Score	-1.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/TLRY pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/TLRY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/TLRY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.5%

Share of float held by funds and institutions

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TSX/TLRY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.6

Neutral momentum band

Price vs 200-day MA

-43.2%

50/200-day relationship not available

Beta (5Y)

2.11

More volatile than the market

Sharpe ratio

0.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/TLRY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/TLRY stock rating?

tsx/TLRY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/TLRY analysis?

The full report lives at /stocks/tsx/TLRY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/TLRY?

The latest report frames tsx/TLRY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/TLRY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.